Shanghai Rongtai Health Technology Corp

Shanghai Rongtai Health Technology Corp FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Shanghai Rongtai Health Technology Corp (603579.SS) as of Oct 11, 2026 is 41.75 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 8.89 % — a change of 369.67% (higher).

FCF Conversion

41.75 %

YoY

369.67%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Shanghai Rongtai Health Technology Corp is 2025 41.75 % . FCF Conversion Rate (FCF/EBITDA) of Shanghai Rongtai Health Technology Corp was 2024 8.89 % . It decreases by 369.67% higher compared to the previous year.

The Shanghai Rongtai Health Technology Corp FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
52.47 CNY
Jan 1, 2019
96.45 CNY
Jan 1, 2020
44.28 CNY
Jan 1, 2021
83.12 CNY
Jan 1, 2022
82.90 CNY
Jan 1, 2023
125.64 CNY
Jan 1, 2024
8.89 CNY
Jan 1, 2025
41.75 CNY
The Shanghai Rongtai Health Technology Corp FCF Conversion history
YEARFCF ConversionYoY
41.75 %+369.67%
8.89 %-92.93%
125.64 %+51.57%
82.90 %-0.27%
83.12 %+87.72%
44.28 %-54.09%
96.45 %+83.82%
52.47 %-7.48%
56.71 %+27.90%
44.34 %-62.98%
119.78 %-5.39%
126.60 %—
Access this data via the Eulerpool API
Get Free API Key

Shanghai Rongtai Health Technology Corp Stock analysis

What does Shanghai Rongtai Health Technology Corp do? Shanghai Rongtai Health Technology Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rongtai Health Technology Corp stock

FCF Conversion Rate (FCF/EBITDA) of Shanghai Rongtai Health Technology Corp is 41.75 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Shanghai Rongtai Health Technology Corp changed from 8.89 % to 41.75 %, representing a 369.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Shanghai Rongtai Health Technology Corp since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Shanghai Rongtai Health Technology Corp with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Shanghai Rongtai Health Technology Corp

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Shanghai Rongtai Health Technology Corp